SEOM guidelines for cervical cancer

doi:10.1007/s12094-015-1452-2

. 2015 Dec;17(12):1036-42.

doi: 10.1007/s12094-015-1452-2. Epub 2015 Dec 9.

SEOM guidelines for cervical cancer

A Oaknin¹, M J Rubio², A Redondo³, A De Juan⁴, J F Cueva Bañuelos⁵, M Gil-Martin⁶, E Ortega⁷, A Garcia-Arias⁸, A Gonzalez-Martin⁹, I Bover¹⁰

Affiliations

¹ Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain. aoaknin@vhio.net.
² Hospital Universitario Reina Sofía de Córdoba, Córdoba, Spain.
³ Hospital Universitario la Paz, Madrid, Spain.
⁴ Hospital Universitario Marqués de Valdecilla, Santander, Spain.
⁵ Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
⁶ Hospital Durán i Reynals (ICO), Barcelona, Spain.
⁷ Hospital Universitari Arnau de Villanova de Lleida, Lleida, Spain.
⁸ Institut Català d'Oncologia, Hospital de Sant Joan Despí-Moisès Broggi, Barcelona, Spain.
⁹ MD Anderson Cancer Center, Madrid, Spain.
¹⁰ Hospital Son Llatzer, Palma de Mallorca, Spain.

PMID: 26650487
PMCID: PMC4689764
DOI: 10.1007/s12094-015-1452-2

SEOM guidelines for cervical cancer

A Oaknin et al. Clin Transl Oncol. 2015 Dec.

. 2015 Dec;17(12):1036-42.

doi: 10.1007/s12094-015-1452-2. Epub 2015 Dec 9.

Authors

A Oaknin¹, M J Rubio², A Redondo³, A De Juan⁴, J F Cueva Bañuelos⁵, M Gil-Martin⁶, E Ortega⁷, A Garcia-Arias⁸, A Gonzalez-Martin⁹, I Bover¹⁰

Affiliations

¹ Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Ps Vall d'Hebron, 119-129, 08035, Barcelona, Spain. aoaknin@vhio.net.
² Hospital Universitario Reina Sofía de Córdoba, Córdoba, Spain.
³ Hospital Universitario la Paz, Madrid, Spain.
⁴ Hospital Universitario Marqués de Valdecilla, Santander, Spain.
⁵ Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
⁶ Hospital Durán i Reynals (ICO), Barcelona, Spain.
⁷ Hospital Universitari Arnau de Villanova de Lleida, Lleida, Spain.
⁸ Institut Català d'Oncologia, Hospital de Sant Joan Despí-Moisès Broggi, Barcelona, Spain.
⁹ MD Anderson Cancer Center, Madrid, Spain.
¹⁰ Hospital Son Llatzer, Palma de Mallorca, Spain.

PMID: 26650487
PMCID: PMC4689764
DOI: 10.1007/s12094-015-1452-2

Abstract

Cervical cancer (CC) is the second most common cancer worldwide, strongly linked to high-risk human papilloma virus infection. Although screening programs have led to a relevant reduction in the incidence and mortality due to CC in developed countries, it is still an important cause of mortality in undeveloped countries. Clinical stage is still the most relevant prognostic factor. In early stages, the primary treatment is surgery or radiotherapy, whereas concomitant chemo-radiotherapy is the conventional approach in locally advanced stages. In the setting of recurrent or metastatic CC, for the first time ever, the combination of chemotherapy plus bevacizumab prolongs the overall survival beyond 12 months. Therefore, this regimen is considered by most of the oncologist a new standard of care for metastatic/recurrent CC.

Keywords: Cervical cancer; Clinical stage; Human papilloma virus.

PubMed Disclaimer

Cited by

The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis.
Yan R, Shuai H, Luo X, Wang X, Guan B. Yan R, et al. Biosci Rep. 2017 Oct 6;37(5):BSR20171021. doi: 10.1042/BSR20171021. Print 2017 Oct 31. Biosci Rep. 2017. PMID: 28883082 Free PMC article.
Ovarian function following targeted anti-angiogenic therapy with bevacizumab.
Imai A, Ichigo S, Matsunami K, Takagi H, Kawabata I. Imai A, et al. Mol Clin Oncol. 2017 Jun;6(6):807-810. doi: 10.3892/mco.2017.1237. Epub 2017 May 5. Mol Clin Oncol. 2017. PMID: 28588768 Free PMC article.
Systematic Review and Network Meta-Analysis of Bevacizumab Plus First-Line Topotecan-Paclitaxel or Cisplatin-Paclitaxel Versus Non-Bevacizumab-Containing Therapies in Persistent, Recurrent, or Metastatic Cervical Cancer.
Rosen VM, Guerra I, McCormack M, Nogueira-Rodrigues A, Sasse A, Munk VC, Shang A. Rosen VM, et al. Int J Gynecol Cancer. 2017 Jul;27(6):1237-1246. doi: 10.1097/IGC.0000000000001000. Int J Gynecol Cancer. 2017. PMID: 28448304 Free PMC article.
Clinical features that affect the number of pelvic lymph nodes harvested in patients with cervical cancer stage IB1 to IIA2.
Choi YJ, Hwang WY, Lee N, Kim M, Suh DH, Kim K, Kim YB, No JH. Choi YJ, et al. Obstet Gynecol Sci. 2021 Jan;64(1):73-79. doi: 10.5468/ogs.20016. Epub 2020 Nov 3. Obstet Gynecol Sci. 2021. PMID: 33137864 Free PMC article.
Development of a Deep Learning Model to Identify Lymph Node Metastasis on Magnetic Resonance Imaging in Patients With Cervical Cancer.
Wu Q, Wang S, Zhang S, Wang M, Ding Y, Fang J, Wu Q, Qian W, Liu Z, Sun K, Jin Y, Ma H, Tian J. Wu Q, et al. JAMA Netw Open. 2020 Jul 1;3(7):e2011625. doi: 10.1001/jamanetworkopen.2020.11625. JAMA Netw Open. 2020. PMID: 32706384 Free PMC article.

See all "Cited by" articles

References

1. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–2686. doi: 10.1093/annonc/mdr015. - DOI - PubMed
1. FIGO Committee on Gynecologic Oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105(2):103–104. doi: 10.1016/j.ijgo.2009.02.012. - DOI - PubMed
1. Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer. 2008;112:1954–1963. doi: 10.1002/cncr.23400. - DOI - PubMed
1. Ramirez PT, Jhingran A, Macapiniac HA, Euscher ED, Munsell MF, Coleman RL, et al. Laparoscopic extraperitoneal Para-aortic lymphadenectomy in locally advanced cervical cáncer. Cancer. 2011;117:1928–1934. doi: 10.1002/cncr.25739. - DOI - PMC - PubMed
1. Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, et al. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014;21:3–8. doi: 10.1016/j.jmig.2013.07.007. - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical

[1] Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–2686. doi: 10.1093/annonc/mdr015. - DOI - PubMed

[2] Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675–2686. doi: 10.1093/annonc/mdr015. - DOI - PubMed

[3] FIGO Committee on Gynecologic Oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105(2):103–104. doi: 10.1016/j.ijgo.2009.02.012. - DOI - PubMed

[4] FIGO Committee on Gynecologic Oncology Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105(2):103–104. doi: 10.1016/j.ijgo.2009.02.012. - DOI - PubMed

[5] Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer. 2008;112:1954–1963. doi: 10.1002/cncr.23400. - DOI - PubMed

[6] Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R. Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer. 2008;112:1954–1963. doi: 10.1002/cncr.23400. - DOI - PubMed

[7] Ramirez PT, Jhingran A, Macapiniac HA, Euscher ED, Munsell MF, Coleman RL, et al. Laparoscopic extraperitoneal Para-aortic lymphadenectomy in locally advanced cervical cáncer. Cancer. 2011;117:1928–1934. doi: 10.1002/cncr.25739. - DOI - PMC - PubMed

[8] Ramirez PT, Jhingran A, Macapiniac HA, Euscher ED, Munsell MF, Coleman RL, et al. Laparoscopic extraperitoneal Para-aortic lymphadenectomy in locally advanced cervical cáncer. Cancer. 2011;117:1928–1934. doi: 10.1002/cncr.25739. - DOI - PMC - PubMed

[9] Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, et al. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014;21:3–8. doi: 10.1016/j.jmig.2013.07.007. - DOI - PMC - PubMed

[10] Frumovitz M, Querleu D, Gil-Moreno A, Morice P, Jhingran A, Munsell MF, et al. Lymphadenectomy in locally advanced cervical cancer study (LiLACS): phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol. 2014;21:3–8. doi: 10.1016/j.jmig.2013.07.007. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

SEOM guidelines for cervical cancer

Affiliations

SEOM guidelines for cervical cancer

Authors

Affiliations

Abstract

Similar articles

Cited by

References

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical